Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients : A multicenter cohort, 2015-2020
Crown Copyright © 2023. Published by Elsevier Inc. All rights reserved..
Solid organ transplant recipients (SOTRs) frequently receive adjunctive glucocorticoid therapy (AGT) for Pneumocystis jirovecii pneumonia (PJP). This multicenter cohort of SOTRs with PJP admitted to 20 transplant centers in Canada, the United States, Europe, and Australia, was examined for whether AGT was associated with a lower rate of all-cause intensive care unit (ICU) admission, 90-day death, or a composite outcome (ICU admission or death). Of 172 SOTRs with PJP (median [IQR] age: 60 (51.5-67.0) years; 58 female [33.7%]), the ICU admission and death rates were 43.4%, and 20.8%, respectively. AGT was not associated with a reduced risk of ICU admission (adjusted odds ratio [aOR] [95% CI]: 0.49 [0.21-1.12]), death (aOR [95% CI]: 0.80 [0.30-2.17]), or the composite outcome (aOR [95% CI]: 0.97 [0.71-1.31]) in the propensity score-adjusted analysis. AGT was not significantly associated with at least 1 unit of the respiratory portion of the Sequential Organ Failure Assessment score improvement by day 5 (12/37 [32.4%] vs 39/111 [35.1%]; P = .78). We did not observe significant associations between AGT and ICU admission or death in SOTRs with PJP. Our findings should prompt a reevaluation of routine AGT administration in posttransplant PJP treatment and highlight the need for interventional studies.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons - 24(2024), 4 vom: 01. Apr., Seite 653-668 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Glucocorticoids |
|---|
| Anmerkungen: |
Date Completed 02.04.2024 Date Revised 10.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ajt.2023.11.003 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM364687665 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM364687665 | ||
| 003 | DE-627 | ||
| 005 | 20240410232304.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ajt.2023.11.003 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1371.xml |
| 035 | |a (DE-627)NLM364687665 | ||
| 035 | |a (NLM)37977229 | ||
| 035 | |a (PII)S1600-6135(23)00858-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hosseini-Moghaddam, Seyed M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients |b A multicenter cohort, 2015-2020 |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.04.2024 | ||
| 500 | |a Date Revised 10.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Crown Copyright © 2023. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a Solid organ transplant recipients (SOTRs) frequently receive adjunctive glucocorticoid therapy (AGT) for Pneumocystis jirovecii pneumonia (PJP). This multicenter cohort of SOTRs with PJP admitted to 20 transplant centers in Canada, the United States, Europe, and Australia, was examined for whether AGT was associated with a lower rate of all-cause intensive care unit (ICU) admission, 90-day death, or a composite outcome (ICU admission or death). Of 172 SOTRs with PJP (median [IQR] age: 60 (51.5-67.0) years; 58 female [33.7%]), the ICU admission and death rates were 43.4%, and 20.8%, respectively. AGT was not associated with a reduced risk of ICU admission (adjusted odds ratio [aOR] [95% CI]: 0.49 [0.21-1.12]), death (aOR [95% CI]: 0.80 [0.30-2.17]), or the composite outcome (aOR [95% CI]: 0.97 [0.71-1.31]) in the propensity score-adjusted analysis. AGT was not significantly associated with at least 1 unit of the respiratory portion of the Sequential Organ Failure Assessment score improvement by day 5 (12/37 [32.4%] vs 39/111 [35.1%]; P = .78). We did not observe significant associations between AGT and ICU admission or death in SOTRs with PJP. Our findings should prompt a reevaluation of routine AGT administration in posttransplant PJP treatment and highlight the need for interventional studies | ||
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Pneumocystis jirovecii | |
| 650 | 4 | |a Pneumocystis pneumonia | |
| 650 | 4 | |a solid organ transplantation | |
| 650 | 7 | |a Glucocorticoids |2 NLM | |
| 700 | 1 | |a Kothari, Sagar |e verfasserin |4 aut | |
| 700 | 1 | |a Humar, Atul |e verfasserin |4 aut | |
| 700 | 1 | |a Albasata, Hanan |e verfasserin |4 aut | |
| 700 | 1 | |a Yetmar, Zachary A |e verfasserin |4 aut | |
| 700 | 1 | |a Razonable, Raymund R |e verfasserin |4 aut | |
| 700 | 1 | |a Neofytos, Dionysios |e verfasserin |4 aut | |
| 700 | 1 | |a D'Asaro, Matilde |e verfasserin |4 aut | |
| 700 | 1 | |a Boggian, Katia |e verfasserin |4 aut | |
| 700 | 1 | |a Hirzel, Cedric |e verfasserin |4 aut | |
| 700 | 1 | |a Khanna, Nina |e verfasserin |4 aut | |
| 700 | 1 | |a Manuel, Oriol |e verfasserin |4 aut | |
| 700 | 1 | |a Mueller, Nicolas J |e verfasserin |4 aut | |
| 700 | 1 | |a Imlay, Hannah |e verfasserin |4 aut | |
| 700 | 1 | |a Kabbani, Dima |e verfasserin |4 aut | |
| 700 | 1 | |a Tyagi, Varalika |e verfasserin |4 aut | |
| 700 | 1 | |a Smibert, Olivia C |e verfasserin |4 aut | |
| 700 | 1 | |a Nasra, Mohamed |e verfasserin |4 aut | |
| 700 | 1 | |a Fontana, Lauren |e verfasserin |4 aut | |
| 700 | 1 | |a Obeid, Karam M |e verfasserin |4 aut | |
| 700 | 1 | |a Apostolopoulou, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Sean X |e verfasserin |4 aut | |
| 700 | 1 | |a Permpalung, Nitipong |e verfasserin |4 aut | |
| 700 | 1 | |a Alhatimi, Hind |e verfasserin |4 aut | |
| 700 | 1 | |a Silverman, Michael S |e verfasserin |4 aut | |
| 700 | 1 | |a Guo, Henry |e verfasserin |4 aut | |
| 700 | 1 | |a Rogers, Benjamin A |e verfasserin |4 aut | |
| 700 | 1 | |a MacKenzie, Erica |e verfasserin |4 aut | |
| 700 | 1 | |a Pisano, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a Gioia, Francesca |e verfasserin |4 aut | |
| 700 | 1 | |a Rapi, Lindita |e verfasserin |4 aut | |
| 700 | 1 | |a Prasad, G V Ramesh |e verfasserin |4 aut | |
| 700 | 1 | |a Banegas, Marcela |e verfasserin |4 aut | |
| 700 | 1 | |a Alonso, Carolyn D |e verfasserin |4 aut | |
| 700 | 1 | |a Doss, Kathleen |e verfasserin |4 aut | |
| 700 | 1 | |a Rakita, Robert M |e verfasserin |4 aut | |
| 700 | 1 | |a Fishman, Jay A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons |d 2001 |g 24(2024), 4 vom: 01. Apr., Seite 653-668 |w (DE-627)NLM119667924 |x 1600-6143 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2024 |g number:4 |g day:01 |g month:04 |g pages:653-668 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ajt.2023.11.003 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2024 |e 4 |b 01 |c 04 |h 653-668 | ||